nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—rheumatoid arthritis	0.167	0.299	CbGaD
Minocycline—ALOX5—rheumatoid arthritis	0.153	0.272	CbGaD
Minocycline—VEGFA—rheumatoid arthritis	0.122	0.218	CbGaD
Minocycline—ALOX5—Sulfasalazine—rheumatoid arthritis	0.122	0.58	CbGbCtD
Minocycline—MMP9—rheumatoid arthritis	0.118	0.211	CbGaD
Minocycline—SLC22A11—Methotrexate—rheumatoid arthritis	0.0238	0.113	CbGbCtD
Minocycline—SLC22A7—Methotrexate—rheumatoid arthritis	0.0227	0.108	CbGbCtD
Minocycline—SLC22A6—Cyclosporine—rheumatoid arthritis	0.0182	0.0867	CbGbCtD
Minocycline—SLC22A8—Methotrexate—rheumatoid arthritis	0.0139	0.0659	CbGbCtD
Minocycline—SLC22A6—Methotrexate—rheumatoid arthritis	0.00965	0.0459	CbGbCtD
Minocycline—IL1B—synovial fluid—rheumatoid arthritis	0.0084	0.12	CbGeAlD
Minocycline—IL1B—knee—rheumatoid arthritis	0.00758	0.108	CbGeAlD
Minocycline—MMP9—synovial fluid—rheumatoid arthritis	0.007	0.1	CbGeAlD
Minocycline—IL1B—skeletal joint—rheumatoid arthritis	0.00543	0.0777	CbGeAlD
Minocycline—MMP9—skeletal joint—rheumatoid arthritis	0.00453	0.0647	CbGeAlD
Minocycline—IL1B—synovial membrane of synovial joint—rheumatoid arthritis	0.00413	0.059	CbGeAlD
Minocycline—IL1B—cartilage tissue—rheumatoid arthritis	0.00365	0.0522	CbGeAlD
Minocycline—MMP9—cartilage tissue—rheumatoid arthritis	0.00304	0.0435	CbGeAlD
Minocycline—CYCS—exocrine gland—rheumatoid arthritis	0.0029	0.0414	CbGeAlD
Minocycline—CASP3—exocrine gland—rheumatoid arthritis	0.00248	0.0355	CbGeAlD
Minocycline—CASP1—connective tissue—rheumatoid arthritis	0.00138	0.0197	CbGeAlD
Minocycline—CYCS—connective tissue—rheumatoid arthritis	0.00133	0.019	CbGeAlD
Minocycline—Doxycycline—MMP13—rheumatoid arthritis	0.0013	0.489	CrCbGaD
Minocycline—CASP3—parotid gland—rheumatoid arthritis	0.00129	0.0185	CbGeAlD
Minocycline—CASP3—connective tissue—rheumatoid arthritis	0.00114	0.0163	CbGeAlD
Minocycline—CASP1—lymphoid tissue—rheumatoid arthritis	0.00101	0.0144	CbGeAlD
Minocycline—CASP1—digestive system—rheumatoid arthritis	0.000996	0.0142	CbGeAlD
Minocycline—CYCS—lymphoid tissue—rheumatoid arthritis	0.000971	0.0139	CbGeAlD
Minocycline—CYCS—digestive system—rheumatoid arthritis	0.000959	0.0137	CbGeAlD
Minocycline—CASP1—tendon—rheumatoid arthritis	0.000948	0.0136	CbGeAlD
Minocycline—IL1B—connective tissue—rheumatoid arthritis	0.000909	0.013	CbGeAlD
Minocycline—Doxycycline—MMP1—rheumatoid arthritis	0.000904	0.339	CrCbGaD
Minocycline—CASP3—lymphoid tissue—rheumatoid arthritis	0.000832	0.0119	CbGeAlD
Minocycline—CASP3—digestive system—rheumatoid arthritis	0.000822	0.0117	CbGeAlD
Minocycline—CASP3—tendon—rheumatoid arthritis	0.000782	0.0112	CbGeAlD
Minocycline—MMP9—connective tissue—rheumatoid arthritis	0.000757	0.0108	CbGeAlD
Minocycline—IL1B—lymphoid tissue—rheumatoid arthritis	0.000664	0.0095	CbGeAlD
Minocycline—IL1B—digestive system—rheumatoid arthritis	0.000656	0.00938	CbGeAlD
Minocycline—IL1B—tendon—rheumatoid arthritis	0.000625	0.00893	CbGeAlD
Minocycline—VEGFA—tendon—rheumatoid arthritis	0.000614	0.00878	CbGeAlD
Minocycline—ALOX5—connective tissue—rheumatoid arthritis	0.000599	0.00856	CbGeAlD
Minocycline—MMP9—lymphoid tissue—rheumatoid arthritis	0.000554	0.00791	CbGeAlD
Minocycline—MMP9—digestive system—rheumatoid arthritis	0.000547	0.00782	CbGeAlD
Minocycline—MMP9—tendon—rheumatoid arthritis	0.00052	0.00744	CbGeAlD
Minocycline—SLC22A11—digestive system—rheumatoid arthritis	0.000518	0.00741	CbGeAlD
Minocycline—SLC22A7—digestive system—rheumatoid arthritis	0.000506	0.00723	CbGeAlD
Minocycline—ALOX5—lymphoid tissue—rheumatoid arthritis	0.000438	0.00626	CbGeAlD
Minocycline—ALOX5—digestive system—rheumatoid arthritis	0.000432	0.00618	CbGeAlD
Minocycline—Methacycline—ALB—rheumatoid arthritis	0.00032	0.12	CrCbGaD
Minocycline—IL1B—Methylprednisolone—Hydrocortisone—rheumatoid arthritis	0.000219	0.0607	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Betamethasone—rheumatoid arthritis	0.000204	0.0564	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Dexamethasone—rheumatoid arthritis	0.000204	0.0564	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Triamcinolone—rheumatoid arthritis	0.000199	0.0551	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Prednisone—rheumatoid arthritis	0.000189	0.0523	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Prednisolone—rheumatoid arthritis	0.000184	0.051	CbGdCrCtD
Minocycline—Tetracycline—ALB—rheumatoid arthritis	0.00014	0.0525	CrCbGaD
Minocycline—IL1B—Fluorometholone—Hydrocortisone—rheumatoid arthritis	0.000136	0.0376	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Methylprednisolone—rheumatoid arthritis	0.000128	0.0355	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Betamethasone—rheumatoid arthritis	0.000126	0.0349	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Dexamethasone—rheumatoid arthritis	0.000126	0.0349	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Triamcinolone—rheumatoid arthritis	0.000123	0.0341	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Prednisone—rheumatoid arthritis	0.000117	0.0324	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Prednisolone—rheumatoid arthritis	0.000114	0.0316	CbGdCrCtD
Minocycline—IL1B—Budesonide—Hydrocortisone—rheumatoid arthritis	9.08e-05	0.0251	CbGdCrCtD
Minocycline—IL1B—Budesonide—Methylprednisolone—rheumatoid arthritis	8.57e-05	0.0237	CbGdCrCtD
Minocycline—IL1B—Budesonide—Dexamethasone—rheumatoid arthritis	8.43e-05	0.0233	CbGdCrCtD
Minocycline—IL1B—Budesonide—Betamethasone—rheumatoid arthritis	8.43e-05	0.0233	CbGdCrCtD
Minocycline—IL1B—Budesonide—Triamcinolone—rheumatoid arthritis	8.24e-05	0.0228	CbGdCrCtD
Minocycline—IL1B—Budesonide—Prednisone—rheumatoid arthritis	7.82e-05	0.0216	CbGdCrCtD
Minocycline—IL1B—Budesonide—Prednisolone—rheumatoid arthritis	7.63e-05	0.0211	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Hydrocortisone—rheumatoid arthritis	5.56e-05	0.0154	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Hydrocortisone—rheumatoid arthritis	5.56e-05	0.0154	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Methylprednisolone—rheumatoid arthritis	5.24e-05	0.0145	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Methylprednisolone—rheumatoid arthritis	5.24e-05	0.0145	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Dexamethasone—rheumatoid arthritis	5.16e-05	0.0143	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Betamethasone—rheumatoid arthritis	5.16e-05	0.0143	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Triamcinolone—rheumatoid arthritis	5.04e-05	0.0139	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Triamcinolone—rheumatoid arthritis	5.04e-05	0.0139	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Prednisone—rheumatoid arthritis	4.78e-05	0.0132	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Prednisone—rheumatoid arthritis	4.78e-05	0.0132	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Prednisolone—rheumatoid arthritis	4.67e-05	0.0129	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Prednisolone—rheumatoid arthritis	4.67e-05	0.0129	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Hydrocortisone—rheumatoid arthritis	2.97e-05	0.00821	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Hydrocortisone—rheumatoid arthritis	2.97e-05	0.00821	CbGdCrCtD
Minocycline—CYCS—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	2.83e-05	0.00784	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Methylprednisolone—rheumatoid arthritis	2.8e-05	0.00774	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Methylprednisolone—rheumatoid arthritis	2.8e-05	0.00774	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Dexamethasone—rheumatoid arthritis	2.75e-05	0.00762	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Betamethasone—rheumatoid arthritis	2.75e-05	0.00762	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Triamcinolone—rheumatoid arthritis	2.69e-05	0.00745	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Triamcinolone—rheumatoid arthritis	2.69e-05	0.00745	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Prednisone—rheumatoid arthritis	2.55e-05	0.00707	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Prednisone—rheumatoid arthritis	2.55e-05	0.00707	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Prednisolone—rheumatoid arthritis	2.49e-05	0.0069	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Prednisolone—rheumatoid arthritis	2.49e-05	0.0069	CbGdCrCtD
Minocycline—CASP3—Signaling Pathways—SH2B3—rheumatoid arthritis	1.09e-05	7.12e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GZMB—rheumatoid arthritis	1.08e-05	7.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—TYK2—rheumatoid arthritis	1.08e-05	7.06e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—VCAM1—rheumatoid arthritis	1.08e-05	7.03e-05	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	1.08e-05	7.02e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DQA1—rheumatoid arthritis	1.08e-05	7.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2RA—rheumatoid arthritis	1.07e-05	7.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.07e-05	6.99e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CAT—rheumatoid arthritis	1.06e-05	6.94e-05	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—rheumatoid arthritis	1.06e-05	6.94e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL3—rheumatoid arthritis	1.05e-05	6.87e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL2—rheumatoid arthritis	1.05e-05	6.87e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6R—rheumatoid arthritis	1.05e-05	6.83e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SAA1—rheumatoid arthritis	1.03e-05	6.72e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL13—rheumatoid arthritis	1.03e-05	6.69e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MMP1—rheumatoid arthritis	1.03e-05	6.69e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—LEP—rheumatoid arthritis	1.01e-05	6.6e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NCF1—rheumatoid arthritis	1.01e-05	6.58e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RBPJ—rheumatoid arthritis	1.01e-05	6.57e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DQB1—rheumatoid arthritis	1.01e-05	6.56e-05	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1e-05	6.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—NFKB1—rheumatoid arthritis	9.93e-06	6.48e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	9.83e-06	6.41e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6R—rheumatoid arthritis	9.76e-06	6.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MAPK8—rheumatoid arthritis	9.76e-06	6.37e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTK2—rheumatoid arthritis	9.72e-06	6.34e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—rheumatoid arthritis	9.7e-06	6.33e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CD28—rheumatoid arthritis	9.7e-06	6.32e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL1A—rheumatoid arthritis	9.55e-06	6.23e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—TYK2—rheumatoid arthritis	9.54e-06	6.22e-05	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	9.53e-06	6.22e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL18—rheumatoid arthritis	9.53e-06	6.22e-05	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—rheumatoid arthritis	9.53e-06	6.21e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6ST—rheumatoid arthritis	9.5e-06	6.2e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD40LG—rheumatoid arthritis	9.5e-06	6.19e-05	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	9.49e-06	6.19e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD8A—rheumatoid arthritis	9.39e-06	6.13e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CSF2—rheumatoid arthritis	9.39e-06	6.13e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—FN1—rheumatoid arthritis	9.36e-06	6.1e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MMP2—rheumatoid arthritis	9.32e-06	6.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS2—rheumatoid arthritis	9.24e-06	6.03e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IRAK1—rheumatoid arthritis	9.23e-06	6.02e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TLE3—rheumatoid arthritis	9.23e-06	6.02e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AGER—rheumatoid arthritis	9.16e-06	5.97e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CX3CR1—rheumatoid arthritis	9.14e-06	5.96e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—UBE2D1—rheumatoid arthritis	9.13e-06	5.95e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ENO1—rheumatoid arthritis	9.11e-06	5.94e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-B—rheumatoid arthritis	9.03e-06	5.89e-05	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	8.99e-06	5.86e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	8.96e-06	5.85e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—BDKRB2—rheumatoid arthritis	8.95e-06	5.84e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL12—rheumatoid arthritis	8.95e-06	5.84e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNG—rheumatoid arthritis	8.93e-06	5.83e-05	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—rheumatoid arthritis	8.93e-06	5.83e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL13—rheumatoid arthritis	8.9e-06	5.81e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TYK2—rheumatoid arthritis	8.89e-06	5.8e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MTHFR—rheumatoid arthritis	8.89e-06	5.8e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADRBK1—rheumatoid arthritis	8.85e-06	5.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	8.82e-06	5.75e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VEGFA—rheumatoid arthritis	8.81e-06	5.75e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2RB—rheumatoid arthritis	8.8e-06	5.74e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD4—rheumatoid arthritis	8.63e-06	5.63e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—rheumatoid arthritis	8.52e-06	5.56e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—C5—rheumatoid arthritis	8.5e-06	5.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6R—rheumatoid arthritis	8.48e-06	5.53e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2RA—rheumatoid arthritis	8.46e-06	5.52e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—C3—rheumatoid arthritis	8.39e-06	5.47e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-A—rheumatoid arthritis	8.37e-06	5.46e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NFATC1—rheumatoid arthritis	8.36e-06	5.45e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RASGRP1—rheumatoid arthritis	8.35e-06	5.45e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SYK—rheumatoid arthritis	8.32e-06	5.43e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRKCQ—rheumatoid arthritis	8.17e-06	5.33e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP2—rheumatoid arthritis	8.09e-06	5.28e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—STAT1—rheumatoid arthritis	8.02e-06	5.23e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IRAK1—rheumatoid arthritis	8.02e-06	5.23e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TLE3—rheumatoid arthritis	8.02e-06	5.23e-05	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—rheumatoid arthritis	8.01e-06	5.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR6—rheumatoid arthritis	7.99e-06	5.21e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CRP—rheumatoid arthritis	7.98e-06	5.21e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—rheumatoid arthritis	7.97e-06	5.2e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2—rheumatoid arthritis	7.94e-06	5.18e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CX3CR1—rheumatoid arthritis	7.94e-06	5.18e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL10—rheumatoid arthritis	7.91e-06	5.16e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.84e-06	5.12e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NCF2—rheumatoid arthritis	7.77e-06	5.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ALB—rheumatoid arthritis	7.77e-06	5.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TYK2—rheumatoid arthritis	7.72e-06	5.03e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR4—rheumatoid arthritis	7.65e-06	4.99e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DRB1—rheumatoid arthritis	7.65e-06	4.99e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2RB—rheumatoid arthritis	7.64e-06	4.98e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SH2B3—rheumatoid arthritis	7.57e-06	4.94e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TRAF6—rheumatoid arthritis	7.57e-06	4.94e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GZMB—rheumatoid arthritis	7.53e-06	4.91e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—NFKB1—rheumatoid arthritis	7.43e-06	4.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS3—rheumatoid arthritis	7.43e-06	4.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—C5—rheumatoid arthritis	7.38e-06	4.81e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—ICAM1—rheumatoid arthritis	7.34e-06	4.79e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6ST—rheumatoid arthritis	7.34e-06	4.79e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—MAPK8—rheumatoid arthritis	7.31e-06	4.77e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL2—rheumatoid arthritis	7.31e-06	4.77e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL3—rheumatoid arthritis	7.31e-06	4.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NFATC1—rheumatoid arthritis	7.26e-06	4.73e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP3—rheumatoid arthritis	7.22e-06	4.71e-05	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	7.17e-06	4.68e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SAA1—rheumatoid arthritis	7.15e-06	4.66e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—POMC—rheumatoid arthritis	7.11e-06	4.64e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD80—rheumatoid arthritis	7.06e-06	4.61e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NCF1—rheumatoid arthritis	7e-06	4.56e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTK2—rheumatoid arthritis	6.95e-06	4.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR6—rheumatoid arthritis	6.94e-06	4.52e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NFKB1—rheumatoid arthritis	6.93e-06	4.52e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL5—rheumatoid arthritis	6.81e-06	4.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—rheumatoid arthritis	6.81e-06	4.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NCF2—rheumatoid arthritis	6.75e-06	4.4e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CD28—rheumatoid arthritis	6.73e-06	4.39e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CSF2—rheumatoid arthritis	6.71e-06	4.38e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TRAF6—rheumatoid arthritis	6.58e-06	4.29e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SH2B3—rheumatoid arthritis	6.58e-06	4.29e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CAT—rheumatoid arthritis	6.56e-06	4.28e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6R—rheumatoid arthritis	6.55e-06	4.27e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GZMB—rheumatoid arthritis	6.53e-06	4.26e-05	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	6.51e-06	4.25e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALB—rheumatoid arthritis	6.48e-06	4.23e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL2—rheumatoid arthritis	6.34e-06	4.14e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL3—rheumatoid arthritis	6.34e-06	4.14e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.34e-06	4.13e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SPP1—rheumatoid arthritis	6.31e-06	4.11e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2—rheumatoid arthritis	6.3e-06	4.11e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—rheumatoid arthritis	6.29e-06	4.1e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—rheumatoid arthritis	6.23e-06	4.07e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL12—rheumatoid arthritis	6.21e-06	4.05e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.21e-06	4.05e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SAA1—rheumatoid arthritis	6.2e-06	4.05e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NOS3—rheumatoid arthritis	6.2e-06	4.04e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.14e-06	4.01e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR5—rheumatoid arthritis	6.13e-06	4e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—rheumatoid arthritis	6.09e-06	3.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—rheumatoid arthritis	6.08e-06	3.97e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NCF1—rheumatoid arthritis	6.08e-06	3.96e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2RA—rheumatoid arthritis	6.05e-06	3.94e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NFKB1—rheumatoid arthritis	6.01e-06	3.92e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—C3—rheumatoid arthritis	6e-06	3.91e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—TYK2—rheumatoid arthritis	5.96e-06	3.89e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CD28—rheumatoid arthritis	5.84e-06	3.81e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.8e-06	3.78e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SYK—rheumatoid arthritis	5.78e-06	3.77e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—rheumatoid arthritis	5.77e-06	3.76e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.67e-06	3.7e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—rheumatoid arthritis	5.67e-06	3.7e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNG—rheumatoid arthritis	5.58e-06	3.64e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LEP—rheumatoid arthritis	5.58e-06	3.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STAT1—rheumatoid arthritis	5.57e-06	3.63e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—UBE2D1—rheumatoid arthritis	5.5e-06	3.59e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL10—rheumatoid arthritis	5.49e-06	3.58e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—rheumatoid arthritis	5.48e-06	3.57e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	5.47e-06	3.57e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL12—rheumatoid arthritis	5.39e-06	3.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BDKRB2—rheumatoid arthritis	5.39e-06	3.52e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—rheumatoid arthritis	5.39e-06	3.52e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—rheumatoid arthritis	5.39e-06	3.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRBK1—rheumatoid arthritis	5.33e-06	3.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—rheumatoid arthritis	5.29e-06	3.45e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FN1—rheumatoid arthritis	5.26e-06	3.43e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6ST—rheumatoid arthritis	5.24e-06	3.42e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CD80—rheumatoid arthritis	5.05e-06	3.29e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.03e-06	3.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SYK—rheumatoid arthritis	5.01e-06	3.27e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—rheumatoid arthritis	5.01e-06	3.27e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MMP3—rheumatoid arthritis	5.01e-06	3.27e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2—rheumatoid arthritis	4.96e-06	3.24e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCQ—rheumatoid arthritis	4.92e-06	3.21e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—rheumatoid arthritis	4.91e-06	3.21e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STAT1—rheumatoid arthritis	4.84e-06	3.15e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTK2—rheumatoid arthritis	4.82e-06	3.14e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—POMC—rheumatoid arthritis	4.79e-06	3.13e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL10—rheumatoid arthritis	4.77e-06	3.11e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL5—rheumatoid arthritis	4.73e-06	3.08e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL2—rheumatoid arthritis	4.69e-06	3.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—rheumatoid arthritis	4.68e-06	3.05e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6R—rheumatoid arthritis	4.68e-06	3.05e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—rheumatoid arthritis	4.67e-06	3.04e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CSF2—rheumatoid arthritis	4.66e-06	3.04e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—NFKB1—rheumatoid arthritis	4.65e-06	3.03e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAPK8—rheumatoid arthritis	4.57e-06	2.98e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	4.57e-06	2.98e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—POMC—rheumatoid arthritis	4.38e-06	2.86e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SPP1—rheumatoid arthritis	4.38e-06	2.86e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—rheumatoid arthritis	4.35e-06	2.84e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP3—rheumatoid arthritis	4.35e-06	2.84e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TYK2—rheumatoid arthritis	4.26e-06	2.78e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR5—rheumatoid arthritis	4.26e-06	2.78e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2RA—rheumatoid arthritis	4.2e-06	2.74e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTK2—rheumatoid arthritis	4.19e-06	2.73e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOS3—rheumatoid arthritis	4.18e-06	2.73e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—C3—rheumatoid arthritis	4.16e-06	2.71e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL5—rheumatoid arthritis	4.1e-06	2.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—rheumatoid arthritis	4.05e-06	2.64e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CSF2—rheumatoid arthritis	4.04e-06	2.64e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—rheumatoid arthritis	3.99e-06	2.6e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LEP—rheumatoid arthritis	3.87e-06	2.53e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NOS3—rheumatoid arthritis	3.82e-06	2.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SPP1—rheumatoid arthritis	3.8e-06	2.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—rheumatoid arthritis	3.78e-06	2.46e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL8—rheumatoid arthritis	3.71e-06	2.42e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR5—rheumatoid arthritis	3.7e-06	2.41e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FN1—rheumatoid arthritis	3.65e-06	2.38e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2RA—rheumatoid arthritis	3.64e-06	2.38e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6ST—rheumatoid arthritis	3.64e-06	2.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—C3—rheumatoid arthritis	3.61e-06	2.36e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2—rheumatoid arthritis	3.54e-06	2.31e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CD80—rheumatoid arthritis	3.5e-06	2.28e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—rheumatoid arthritis	3.49e-06	2.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LEP—rheumatoid arthritis	3.36e-06	2.19e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—rheumatoid arthritis	3.35e-06	2.19e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—POMC—rheumatoid arthritis	3.33e-06	2.17e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NFKB1—rheumatoid arthritis	3.32e-06	2.17e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK8—rheumatoid arthritis	3.26e-06	2.13e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL2—rheumatoid arthritis	3.26e-06	2.12e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6R—rheumatoid arthritis	3.25e-06	2.12e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FN1—rheumatoid arthritis	3.17e-06	2.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6ST—rheumatoid arthritis	3.16e-06	2.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CD80—rheumatoid arthritis	3.04e-06	1.98e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—rheumatoid arthritis	3.01e-06	1.96e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TYK2—rheumatoid arthritis	2.96e-06	1.93e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—rheumatoid arthritis	2.92e-06	1.9e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOS3—rheumatoid arthritis	2.9e-06	1.89e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—POMC—rheumatoid arthritis	2.89e-06	1.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL2—rheumatoid arthritis	2.83e-06	1.84e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6R—rheumatoid arthritis	2.82e-06	1.84e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—rheumatoid arthritis	2.76e-06	1.8e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL8—rheumatoid arthritis	2.57e-06	1.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TYK2—rheumatoid arthritis	2.57e-06	1.67e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOS3—rheumatoid arthritis	2.52e-06	1.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2—rheumatoid arthritis	2.46e-06	1.61e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NFKB1—rheumatoid arthritis	2.3e-06	1.5e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—rheumatoid arthritis	2.28e-06	1.48e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK8—rheumatoid arthritis	2.26e-06	1.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL8—rheumatoid arthritis	2.24e-06	1.46e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2—rheumatoid arthritis	2.14e-06	1.39e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—rheumatoid arthritis	2.09e-06	1.36e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—rheumatoid arthritis	2.08e-06	1.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—rheumatoid arthritis	2.02e-06	1.32e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NFKB1—rheumatoid arthritis	2e-06	1.3e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK8—rheumatoid arthritis	1.97e-06	1.28e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—rheumatoid arthritis	1.92e-06	1.25e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—rheumatoid arthritis	1.67e-06	1.09e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—rheumatoid arthritis	1.58e-06	1.03e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—rheumatoid arthritis	1.45e-06	9.43e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—rheumatoid arthritis	1.37e-06	8.95e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—rheumatoid arthritis	1.26e-06	8.19e-06	CbGpPWpGaD
